Congress Asset Management Co. Buys 6,473 Shares of HealthEquity, Inc. $HQY

Congress Asset Management Co. grew its stake in HealthEquity, Inc. (NASDAQ:HQY) by 9.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,714 shares of the company’s stock after buying an additional 6,473 shares during the quarter. Congress Asset Management Co. owned approximately 0.09% of HealthEquity worth $7,081,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Cresset Asset Management LLC increased its holdings in HealthEquity by 32.7% in the 1st quarter. Cresset Asset Management LLC now owns 5,347 shares of the company’s stock worth $473,000 after acquiring an additional 1,317 shares in the last quarter. Hsbc Holdings PLC increased its stake in shares of HealthEquity by 14.7% in the first quarter. Hsbc Holdings PLC now owns 3,089 shares of the company’s stock worth $273,000 after purchasing an additional 395 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of HealthEquity during the 1st quarter valued at $65,000. Credit Agricole S A lifted its stake in shares of HealthEquity by 29.1% during the 1st quarter. Credit Agricole S A now owns 33,496 shares of the company’s stock valued at $2,960,000 after buying an additional 7,550 shares in the last quarter. Finally, Martingale Asset Management L P purchased a new position in shares of HealthEquity during the 1st quarter valued at $248,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

HQY stock opened at $95.50 on Monday. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The stock has a market capitalization of $8.16 billion, a price-to-earnings ratio of 43.81, a price-to-earnings-growth ratio of 1.38 and a beta of 0.18. The firm’s fifty day simple moving average is $97.22 and its two-hundred day simple moving average is $96.32.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. During the same quarter last year, the firm earned $0.78 earnings per share. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

HQY has been the subject of several research analyst reports. Barclays assumed coverage on HealthEquity in a research report on Monday, December 8th. They set an “overweight” rating and a $118.00 target price for the company. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. JMP Securities set a $122.00 price objective on shares of HealthEquity in a research report on Thursday, December 4th. Barrington Research reissued an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a report on Thursday, December 4th. Finally, Citizens Jmp upped their target price on shares of HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research report on Thursday, December 4th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and an average price target of $120.27.

Insiders Place Their Bets

In related news, EVP Michael Henry Fiore sold 1,781 shares of HealthEquity stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares in the company, valued at $4,392,416.95. This trade represents a 3.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president directly owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. This trade represents a 1.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,740 shares of company stock worth $1,498,084 over the last quarter. Company insiders own 1.50% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.